These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28605582)

  • 1. Assessing Antibiotic Permeability of Gram-Negative Bacteria via Nanofluidics.
    Hong S; Moritz TJ; Rath CM; Tamrakar P; Lee P; Krucker T; Lee LP
    ACS Nano; 2017 Jul; 11(7):6959-6967. PubMed ID: 28605582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thinking outside the "bug": a unique assay to measure intracellular drug penetration in gram-negative bacteria.
    Zhou Y; Joubran C; Miller-Vedam L; Isabella V; Nayar A; Tentarelli S; Miller A
    Anal Chem; 2015 Apr; 87(7):3579-84. PubMed ID: 25753586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding efflux in Gram-negative bacteria: opportunities for drug discovery.
    Schweizer HP
    Expert Opin Drug Discov; 2012 Jul; 7(7):633-42. PubMed ID: 22607346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress against Escherichia coli with the Oxazolidinone Class of Antibacterials: Test Case for a General Approach To Improving Whole-Cell Gram-Negative Activity.
    Takrouri K; Cooper HD; Spaulding A; Zucchi P; Koleva B; Cleary DC; Tear W; Beuning PJ; Hirsch EB; Aggen JB
    ACS Infect Dis; 2016 Jun; 2(6):405-26. PubMed ID: 27627629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationalizing the permeation of polar antibiotics into Gram-negative bacteria.
    Scorciapino MA; Acosta-Gutierrez S; Benkerrou D; D'Agostino T; Malloci G; Samanta S; Bodrenko I; Ceccarelli M
    J Phys Condens Matter; 2017 Mar; 29(11):113001. PubMed ID: 28155846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances and challenges in bacterial compound accumulation assays for drug discovery.
    Six DA; Krucker T; Leeds JA
    Curr Opin Chem Biol; 2018 Jun; 44():9-15. PubMed ID: 29803973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of envelope permeability and antibiotic influx and efflux in Gram-negative bacteria.
    Masi M; Réfregiers M; Pos KM; Pagès JM
    Nat Microbiol; 2017 Feb; 2():17001. PubMed ID: 28224989
    [No Abstract]   [Full Text] [Related]  

  • 8. Essential oils from Moroccan plants as potential chemosensitisers restoring antibiotic activity in resistant Gram-negative bacteria.
    Fadli M; Chevalier J; Saad A; Mezrioui NE; Hassani L; Pages JM
    Int J Antimicrob Agents; 2011 Oct; 38(4):325-30. PubMed ID: 21752605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Permeability barriers of Gram-negative pathogens.
    Zgurskaya HI; Rybenkov VV
    Ann N Y Acad Sci; 2020 Jan; 1459(1):5-18. PubMed ID: 31165502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial membrane destabilization with cationic particles of nano-silver to combat efflux-mediated antibiotic resistance in Gram-negative bacteria.
    Anuj SA; Gajera HP; Hirpara DG; Golakiya BA
    Life Sci; 2019 Aug; 230():178-187. PubMed ID: 31152810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Throughput Flow Cytometry Screening of Multidrug Efflux Systems.
    Haynes MK; Garcia M; Peters R; Waller A; Tedesco P; Ursu O; Bologa CG; Santos RG; Pinilla C; Wu TH; Lovchik JA; Oprea TI; Sklar LA; Tegos GP
    Methods Mol Biol; 2018; 1700():293-318. PubMed ID: 29177837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular Quantification of Uptake in Gram-Negative Bacteria.
    Prochnow H; Fetz V; Hotop SK; García-Rivera MA; Heumann A; Brönstrup M
    Anal Chem; 2019 Feb; 91(3):1863-1872. PubMed ID: 30485749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive compound accumulation rules yield a broad-spectrum antibiotic.
    Richter MF; Drown BS; Riley AP; Garcia A; Shirai T; Svec RL; Hergenrother PJ
    Nature; 2017 May; 545(7654):299-304. PubMed ID: 28489819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the Kinetics of the Permeation of Antibacterial Agents into Growing Bacteria and Its Interplay with Efflux.
    Nichols WW
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28717042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Diversity of Gram-Negative Permeability Barriers Reflected in Antibacterial Activities and Intracellular Accumulation of Antibiotics.
    Leus IV; Adamiak J; Chandar B; Bonifay V; Zhao S; Walker SS; Squadroni B; Balibar CJ; Kinarivala N; Standke LC; Voss HU; Tan DS; Rybenkov VV; Zgurskaya HI
    Antimicrob Agents Chemother; 2023 Feb; 67(2):e0137722. PubMed ID: 36715507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the cell wall on ciprofloxacin susceptibility in selected wild-type Gram-negative and Gram-positive bacteria.
    Berlanga M; Montero MT; Hernández-Borrell J; Viñas M
    Int J Antimicrob Agents; 2004 Jun; 23(6):627-30. PubMed ID: 15194135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bifurcation kinetics of drug uptake by Gram-negative bacteria.
    Westfall DA; Krishnamoorthy G; Wolloscheck D; Sarkar R; Zgurskaya HI; Rybenkov VV
    PLoS One; 2017; 12(9):e0184671. PubMed ID: 28926596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of antibiotic efflux in Gram-negative bacteria.
    Zgurskaya HI; Krishnamoorthy G; Tikhonova EB; Lau SY; Stratton KL
    Front Biosci; 2003 Sep; 8():s862-73. PubMed ID: 12957812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creative targeting of the Gram-negative outer membrane in antibiotic discovery.
    MacNair CR; Tsai CN; Brown ED
    Ann N Y Acad Sci; 2020 Jan; 1459(1):69-85. PubMed ID: 31762048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-infectives in Drug Delivery-Overcoming the Gram-Negative Bacterial Cell Envelope.
    Graef F; Gordon S; Lehr CM
    Curr Top Microbiol Immunol; 2016; 398():475-496. PubMed ID: 26942419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.